FDA updates label of 33-year-old cancer drug with new dose and warning
The FDA on Wednesday updated the label for Sandoz’s decades-old leukemia drug fludarabine phosphate, as part of a wider initiative to revamp the labels for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
